Key Takeaways FDA has launched an aggressive new crackdown on direct-to-consumer (DTC) drug advertising, issuing nearly 100 cease-and-desist letters and thousands of notices — many targeting ...

While the recent plan to crack down on DTC drug ads won't make much of an impact, we agree with the Trump administration that ...

A spokesperson for the Denver Police Department told CBS News Colorado that the ad campaign has had no effect on staffing ...

Federal health officials are cracking down on telehealth companies’ promotion of unapproved versions of prescription drugs.

Legal and regulatory experts expect litigation to arise if the FDA seeks to enforce its pharma DTC ad crackdown, though how it might play out is nuanced.

The FDA asserted that the 90-second TV ad misbrands Novartis’ Fabhalta and makes the distribution of the drug in violation of the Federal Food, Drug, and Cosmetic Act.

Opinion: Lawsuit ads warning about prescription drugs or medical devices generate fear that can put patients at risk.

There are plenty of good reasons to <a href=" the TV advertising of prescription drugs, but coming from the anti-science, ...

Pharmaceutical ads now account for 9% of TV advertising according to LightShed Partner’s Richard Greenfield and an even ...

For the past 30 years, turn on the television and, at some point, you’ve likely encountered an “ask your doctor” ad. They’re ...

Direct-to-consumer drug ads have long blurred the line between patient empowerment and corporate persuasion, but the FDA is ...

The ad, which flashes images of ICE agents leading people away in handcuffs, urges officers to join ICE, to help “catch the ...